MedTrace Logo

Drug Use Study With VYVANSE® in Australia for Binge Eating Disorder

NCT04866043 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2021-11-22

No results posted yet for this study

Summary

This study will check how and to whom Vyvanse is prescribed in Australia by retrospectively analyzing a prescription database with additional information provided by a physician survey.

Conditions

  • Binge-eating Disorder

Sponsors & Collaborators

  • Shire

    lead INDUSTRY

Principal Investigators

  • Study Director · Shire

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2021-10-15
Completion
2021-10-15

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04866043 on ClinicalTrials.gov